The Changes in the Laboratory Values During Administration of Commercially Available Ready-to-use Basal Solutions for Total Parenteral Nutrition

Some differences are seen in the concentrations of glucose and electrolytes between commercially available ready-to-use basal solutions for total parenteral nutrition (R-TPN). In this study, we investigated the effects of the long-term administration of Unicaliq®, which contains relatively higher co...

Full description

Saved in:
Bibliographic Details
Published inIryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences) Vol. 27; no. 1; pp. 33 - 40
Main Authors Kimura, Yasuhiro, Sato, Eiji, Kihira, Kenji, Kitaura, Teruaki, Fukuchi, Hiroshi, Miyake, Katsushi, Arai, Shigeaki, Sakai, Masahiko, Ikeda, Hiroaki
Format Journal Article
LanguageJapanese
Published Japanese Society of Pharmaceutical Health Care and Sciences 2001
Subjects
Online AccessGet full text
ISSN1346-342X
1882-1499
DOI10.5649/jjphcs.27.33

Cover

More Information
Summary:Some differences are seen in the concentrations of glucose and electrolytes between commercially available ready-to-use basal solutions for total parenteral nutrition (R-TPN). In this study, we investigated the effects of the long-term administration of Unicaliq®, which contains relatively higher concentrations of chloride ions than other R-TPNs, on the clinical laboratory values. One hundred and nineteen patients, who received Unicaliq® for more than four weeks at Hiroshima University Hospital, participated in this study. The laboratory values of chloride ion (Cl-) and blood urea nitrogen (BUN) significantly increased after receiving Unicaliq® for 2 weeks, but all levels, except for BUN, returned to the pretreatment levels after 4 weeks of administration. However, these changes were slight and all were within the normal ranges. No changes were observed in other laboratory values during the 4-week administration period. These results suggest that the clinical laboratory values are not affected by the long-term administration of Unicaliq®, at least up until 4 weeks.
ISSN:1346-342X
1882-1499
DOI:10.5649/jjphcs.27.33